Table 3.

Use of vasopressors over time between the treated and control groups

	Any vasopressor		Dopamine		Epinephrine
	OR [95% CI]	p	OR [95% CI]	p	OR [95% CI]	p
Day 0	0.29 [0.04, 1.22]	0.125	0.82 [0.43, 1.55]	0.532	0.96 [0.53, 1.73]	0.884
Day 1	0.89 [0.41, 1.94]	0.776	0.75 [0.34, 0.94]	0.048	1.05 [0.59, 1.86]	0.872
Day 2	0.80 [0.48, 1.35]	0.410	0.55 [0.23, 0.91]	0.039	0.98 [0.61, 1.56]	0.933
Day 3	0.74 [0.48, 1.15]	0.183	0.45 [0.15, 0.88]	0.021	0.90 [0.58, 1.39]	0.635
Day 4	0.76 [0.48, 1.21]	0.249	0.42 [0.13, 0.82]	0.012	0.98 [0.61, 1.58]	0.944
Day 5	0.84 [0.50, 0.93]	0.041	0.66 [0.17, 2.35]	0.523	0.88 [0.50, 1.55]	0.666
Day 6	0.66 [0.37, 0.95]	0.043	0.75 [0.15, 3.46]	0.710	0.67 [0.35, 0.86]	0.022

Logistic regression models were fitted with the use of any, dopamine or epinephrine as the response variable and the treatment group as the independent variable. The models were stratified by the ICU days from 0 to 6. OR < 1 indicates lower requirement of vasopressors for the treated groups against the control group